Purdue Pharma Ceases, Becomes New Nonprofit

Purdue Pharma ceases, becomes new nonprofit

NEW YORK — Purdue Pharma said Friday it ceased operations and concluded its bankruptcy, re-emerging as a nonprofit focused on treating opioid addiction, overseen by a new board with government and health industry experience.

Purdue Pharma Emerges From Bankruptcy as Nonprofit Focused on Opioid Addiction Treatment

Purdue Pharma announced on Friday that it has officially завершed its bankruptcy process and ceased operating in its former corporate structure, re-emerging as a nonprofit ... The post Purdue Pharma Emerges From Bankruptcy as Nonprofit Focused on Opioid Addiction Treatment first appeared on [your]NEWS.

Purdue Pharma Re-emerges as Nonprofit Entity

Purdue Pharma has announced it has ceased operations and concluded its multi-year bankruptcy proceedings, re-emerging as a nonprofit organisation, Knoa Pharma. The new entity is dedicated to treating opioid addiction and will be overseen by a new board comprising individuals with government and health industry experience. Purdue Pharma was a pharmaceutical company known for developing and marketing the painkiller OxyContin, and it had faced thou…

As Purdue shuts down, Knoa Pharma opens under a no-promotion opioid rule

Owned by a new nonprofit foundation, Knoa says business value will fund U.S. opioid-abatement efforts and no-profit overdose medicines.

After Waiting Years for Justice, Many Purdue Pharma Opioid Victims are Defeated – by Paperwork

News The Purdue Pharma bankruptcy settlement set aside $865 million to compensate individuals harmed by America’s opioid crisis, but over 40 percent of claims have already been rejected. [Source: reuters.com] [Image source: freepik.com] Comment Although nearly 140,000 people submitted claims in 2021, many are discovering too late that they must provide detailed proof that the opioids they or their loved o…